ESMA_QA_2872
Topic
EU-CCPs
22/06/2026
Subject Matter
AAR representativeness and intragroup transactions
Question
Can an entity, which is part of a group subject to consolidated supervision, rely on intragroup transactions to fulfil the requirements of the representativeness obligation set out under Article 7a(3), point d, of EMIR?
Level 1 Regulation
Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs
ESMA_QA_2867
Topic
EU-CCPs
15/06/2026
Subject Matter
Impact of the new clearing obligation thresholds on the AAR scope
Question
Under the new clearing threshold regime which distinguishes between financial and non-financial counterparties, and uncleared and cleared trades, how should the second AAR condition referred to under Article 7a(1) of EMIR be assessed?
Level 1 Regulation
Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs
ESMA_QA_2831
Topic
EU-CCPs
07/04/2026
Subject Matter
Treatment of assets and positions of affiliates of a clearing member as proprietary assets and positions of that clearing member by CCPs
Question
May CCPs treat assets and positions of affiliates of clearing members as proprietary assets and positions of the clearing member as indicated in RTSs 153/2013 and 149/2013?
Level 1 Regulation
Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs
ESMA_QA_2779
Topic
EU-CCPs
16/02/2026
Subject Matter
AAR threshold calculation
Question
In calculating the second AAR condition under Article 7a(1) of EMIR, should only cleared interest rate derivatives be included, or both cleared and uncleared?
Level 1 Regulation
Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs
ESMA_QA_2778
Topic
EU-CCPs
16/02/2026
Subject Matter
AAR stress testing
Question
In accordance with Article 7a(4) of EMIR, the AAR requirements set out under points (a), (b), and (c) of Article 7a(3) shall be “regularly stress-tested at least once a year”. In relation to the stress-testing referred to under Article 7a(4) of EMIR:
- Should the stress testing apply to three times the trade count or to the gross notional value cleared?
- Should the stress testing apply for each type of products under Article 6 of Commission Delegated Regulation (EU) 2026/305, or at subcategories or account level ?
- What is the timeline for the first annual stress test?
Level 1 Regulation
Regulation 648/2012 - OTC derivatives, central counterparties and trade repositories (EMIR) - CCPs